Table 1:
Comparison of patients with HF separated into those with and without advanced HF during hospitalization.
| Non-advanced HF (N=717) |
Advanced HF (N=144) |
HF (N=861) | p value | |
|---|---|---|---|---|
| Age | 76.3 (65.7, 84.3) | 76.4 (66.6, 86.0) | 76.4 (65.8, 84.4) | 0.545 |
| Female | 313 (43.7%) | 67 (46.5%) | 380 (44.1%) | 0.526 |
| Charlson Index | 3.0 (1.0, 6.0) | 5.0 (3.0, 8.0) | 3.0 (1.0, 6.0) | < 0.001 |
| Admission diagnosis of shock | 136 (19.0%) | 21 (14.6%) | 157 (18.2%) | 0.214 |
| Day 1 SOFA | 3.0 (1.0, 6.0) | 4.0 (3.0, 7.0) | 3.0 (2.0, 6.0) | < 0.001 |
| APACHE III | 63.0 (51.0, 78.0) | 69.0 (55.0, 83.0) | 63.0 (51.0, 79.0) | 0.005 |
| LVEF (%) | 40 (30, 55) | 37 (22, 56) | 40 (30, 55) | 0.114 |
| Invasive Vent | 128 (17.9%) | 20 (13.9%) | 148 (17.2%) | 0.250 |
| Noninvasive Vent | 198 (27.6%) | 57 (39.6%) | 255 (29.6%) | 0.004 |
| Vasoactive drugs | 162 (22.6%) | 53 (36.8%) | 215 (25.0%) | < 0.001 |
| Temporary MCS | 77 (10.7%) | 9 (6.2%) | 86 (10.0%) | 0.101 |
| PAC | 53 (7.4%) | 28 (19.4%) | 81 (9.4%) | < 0.001 |
| Dialysis | 31 (4.3%) | 11 (7.6%) | 42 (4.9%) | 0.092 |
| Admission chloride | 102.0 (99.0, 105.0) | 99.0 (95.0, 103.8) | 102.0 (98.0, 105.0) | < 0.001 |
| Admission BUN | 23.0 (17.0, 35.0) | 36.0 (22.0, 58.0) | 24.0 (17.0, 37.0) | < 0.001 |
| Admission creatinine | 1.1 (0.9, 1.6) | 1.5 (1.1, 2.3) | 1.2 (0.9, 1.7) | < 0.001 |
| Admission RDW | 14.4 (13.6, 15.6) | 16.0 (14.6, 17.2) | 14.6 (13.7, 16.0) | < 0.001 |
| In-hospital mortality | 71 (9.9%) | 26 (18.1%) | 97 (11.3%) | 0.005 |
| One-year mortality* | 117 (18.1%) | 56 (47.5%) | 173 (22.6%) | < 0.001 |
| Rehospitalization by 1 year* | 299 (46.4%) | 64 (54.2%) | 363 (47.6%) | 0.115 |
| Death or rehospitalization by 1 year* | 379 (58.8%) | 102 (86.4%) | 481 (63.0%) | < 0.001 |
*
Among hospital survivors (n = 764)